Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing

Cited by (418)

Items 101–200 of 418

1. Prevention and Treatment of Atherosclerosis: A Practitioner's Guide for 2008
   Sandra J. Lewis · 2008 · The American Journal of Medicine
2. Dietary treatment for familial hypercholesterolaemia
   Nusrat Shafiq, Meenu Singh, Sharonjeet Kaur, Pratibha Khosla, Samir Malhotra · 2010 · Cochrane Database of Systematic Reviews
3. The Influence of Adolescent Body Mass Index, Physical Activity, and Tobacco Use on Blood Pressure and Cholesterol in Young Adulthood
   Carol Ann Ford, James M. Nonnemaker, Kathleen E. Wirth · 2008 · Journal of Adolescent Health
4. Reducing the burden of coronary artery disease in India: challenges and opportunities.
   Enas A Enas, Vibhuti N. Singh, Y P Munjal, Suman Bhandari, Ram Deo Yadave, Subhash Chand Manchanda · 2008 · PubMed
5. Surface Roughness Detection of Arteries via Texture Analysis of Ultrasound Images for Early Diagnosis of Atherosclerosis
   Lili Niu, Ming Qian, Wei Yang, Long Meng, Yang Xiao, Kelvin K. L. Wong, Derek Abbott, Xin Liu, Hairong Zheng · 2013 · PLoS ONE
6. Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
   Martin Prøven Bogsrud, Gisle Langslet, Cecilie Wium, Dan Johansen, Arne Svilaas, Kirsten Bjørklund Holven · 2017 · Journal of clinical lipidology
7. Systematic Review and Metaanalysis of Statins for Heterozygous Familial Hypercholesterolemia in Children: Evaluation of Cholesterol Changes and Side Effects
   Clodagh S. O’Gorman, Mary Higgins, Michael B. O’Neill · 2009 · Pediatric Cardiology
8. Impaired Fetal Growth, Cardiovascular Disease, and the Need to Move on
   Wulf Palinski, Claudio Napoli A · 2008 · Circulation
9. Lipid Screening in Children and Adolescents in Community Practice: 2007 to 2010
   Karen L. Margolis, Louise C. Greenspan, Nicole K. Trower, Matthew F. Daley, Stephen R. Daniels, Joan Chia-Mei Lo, Elyse Olshen Kharbanda, Alan R. Sinaiko, David J. Magid, Emily D. Parker et al. · 2014 · Circulation Cardiovascular Quality and Outcomes
10. 2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents
    Jung Sub Lim, Eun Young Kim, Jae Hyun Kim, Jae-Ho Yoo, Kyung Hee Yi, Hyun Wook Chae, Jin‐Ho Choi, Ji Young Kim, Il Tae Hwang · 2020 · Annals of Pediatric Endocrinology & Metabolism
11. Treatment of Dyslipidaemia in Children
    Riccardo Fiorentino, Francesco Chiarelli · 2021 · Biomedicines
12. Management recommendations for metabolic complications associated with second generation antipsychotic use in children and youth.
    Josephine Ho, Constadina Panagiotopoulos, Brian W. McCrindle, Silviu Grisaru, Tamara Milka Pringsheim · 2011 · PubMed Central
13. Pediatric Atorvastatin in Diabetes Trial (PADIT): A Pilot Study to Determine the Effect of Atorvastatin on Arterial Stiffness and Endothelial Function in Children with Type 1 Diabetes Mellitus
    Michael J. Haller, Joerg-Ingolf Stein, Jonathan J. Shuster, Douglas W. Theriaque, Margaret M. Samyn, Carl J. Pepine, Janet H. Silverstein · 2009 · Journal of Pediatric Endocrinology and Metabolism
14. Longitudinal Changes in Carotid Intima-Media Thickness and Cardiovascular Risk Factors in Human Immunodeficiency Virus-Infected Children and Young Adults Compared With Healthy Controls
    Allison C. Ross, Norma J. Storer, Mary Ann O’Riordan, Vikram Singh Dogra, Grace A. McComsey · 2010 · The Pediatric Infectious Disease Journal
15. Management recommendations for metabolic complications associated with second-generation antipsychotic use in children and youth
    MD MSc Josephine Ho, Constadina Panagiotopoulos, Brian W. McCrindle, Silviu Grisaru, Tamara Milka Pringsheim, The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) guideline group · 2011 · Paediatrics & Child Health
16. Type 2 diabetes in childhood: epidemiological and clinical aspects
    Krystyna A. Matyka · 2008 · British Medical Bulletin
17. Statins in Children, an Update
    Riccardo Fiorentino, Francesco Chiarelli · 2023 · International Journal of Molecular Sciences
18. Assessment of childhood obesity in secondary care: OSCA consensus statement
    Russell Viner, Billy White, Timothy Geoffrey Barrett, David C. A. Candy, Penny Gibson, John W Gregory, Krystyna A. Matyka, Ken K. Ong, Edna Frances Roche, Mary Catharine Joy Rudolf et al. · 2012 · Archives of Disease in Childhood Education & Practice
19. Optimal management of familial hypercholesterolemia: treatment and management strategies
    Mohammad Hassan Nemati, Behrooz Astaneh · 2010 · Vascular Health and Risk Management
20. Familial hypercholesterolemia and triglyceride metabolism
    Genovefa D. Kolovou, Peggy M Kostakou, Katherine K. Anagnostopoulou · 2010 · International Journal of Cardiology
21. Special Supplemental Nutrition Program For Women, Infants, and Children
    Colorado Wic Formula Guide · 2011
22. A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia
    Gisle Langslet, Andrei Breazna, Euridiki Drogari · 2016 · Journal of clinical lipidology
23. A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (LDL-C) and type 1 diabetes
    Jose A. Canas, JUDITH LEVINE ROSS, Martha Taboada, Kaitlin Sikes, Ligeia C Damaso, Jobayer Hossain, Michael P. Caulfield, Samuel S. Gidding, Nelly Mauras · 2014 · Pediatric Diabetes
24. Dyslipidemia in type 1 diabetes mellitus: Relation to diabetes duration, glycemic control, body habitus, dietary intake and other epidemiological risk factors
    Hassan M. Mona, Sahar Abd El-Atty Sharaf, Hend Mehawed Abdel Latif Soliman, Al-Wakeel A. Nanees · 2015 · Egyptian Pediatric Association Gazette
25. Comorbidities and microvascular complications of type 2 diabetes in children and adolescents
    Heather Dean, Elizabeth A. C. Sellers · 2007 · Pediatric Diabetes
26. Physical fitness, dietary intake, and metabolic control in adolescents with type 1 diabetes
    Sara Fleet Michaliszyn, Gabriel Q. Shaibi, Lauretta T. Quinn, Cynthia Fritschi, Melissa Spezia Faulkner · 2009 · Pediatric Diabetes
27. Phase I/IIa Trial of Atorvastatin in Patients with Acute Kawasaki Disease with Coronary Artery Aneurysm
    Adriana H. Tremoulet, Sonia Jain, Pei‐Ni Jone, Brookie M. Best, Elizabeth Duxbury, Alessandra Franco, Beth Feller Printz, Samuel R. Dominguez, Heather R. Heizer, Marsha S. Anderson et al. · 2019 · The Journal of Pediatrics
28. Lipid Management in Children
    Frances R. Zappalla, Samuel S. Gidding · 2009 · Endocrinology and Metabolism Clinics of North America
29. Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program
    Hans J. Avis, D. Meeike Kusters, Maud N. Vissers, Roeland Huijgen, Thomas H. Janssen, Albert Wiegman, Iris Kindt, John J.P. Kastelein, Frits A. Wijburg, Barbara A. Hutten · 2012 · The Journal of Pediatrics
30. Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter
    Holly C. Gooding, Sarah D. de Ferranti · 2010 · Current Opinion in Pediatrics
31. Carotid arterial stiffness in overweight and obese Indian children
    Deepa Pandit, Arun S. Kinare, Shashi Ajit Chiplonkar, Anuradha Vaman Khadilkar, Vaman V Khadilkar · 2011 · Journal of Pediatric Endocrinology and Metabolism
32. Obesity and Dyslipidemia in Behaviorally HIV‐Infected Young Women: Adolescent Trials Network Study 021
    Kathleen M. Mulligan, D. Robert Harris, Dina Monte, Sonia Stoszek, Patricia J Emmanuel, Dana Sue Hardin, Bill G. Kapogiannis, Carol J. Worrell, William A. Meyer, John W. Sleasman et al. · 2009 · Clinical Infectious Diseases
33. Association between different growth curve definitions of overweight and obesity and cardiometabolic risk in children
    Lisa Kakinami, Mélanie Henderson, EDGARD E. DELVIN, Emile H. Levy, Jennifer L O’Loughlin, Marie A. Lambert, Gilles Paradis · 2012 · Canadian Medical Association Journal
34. Insulin Resistance and Parental Obesity as Predictors to Response to Therapeutic Life Style Change in Obese Children and Adolescents 10–18 Years Old
    Orit Pinhas‐Hamiel, Liat Lerner‐Geva, Nancy M. Copperman, Marc S. Jacobson · 2008 · Journal of Adolescent Health
35. Early increase of carotid intima-media thickness in children with parental history of premature myocardial infarction
    S. Barra, G Gaeta, S Cuomo, Pasquale Guarini, M Foglia, Giovanbattista Capozzi, Crescenzo Materazzi, Maurizio Trevisan · 2009 · Heart
36. Atorvastatin Safety in Kawasaki Disease Patients With Coronary Artery Aneurysms
    Elizabeth Niedra, Nita Chahal, Cedric Manlhiot, Rae S. M. Yeung, Brian W. McCrindle · 2013 · Pediatric Cardiology
37. Lipid-lowering medications for children and adolescents
    Melissa L. Miller, Chanin Wright, Barry A. Browne · 2015 · Journal of clinical lipidology
38. Evaluation and management of hyperlipidemia in children and adolescents
    Lorenzo Iughetti, Patrizia Bruzzi, Barbara Predieri · 2010 · Current Opinion in Pediatrics
39. Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
    Shaker A. Mousa · 2010 · Vascular Health and Risk Management
40. Pharmacogenetics in Clinical Pediatrics: Challenges and Strategies
    Sara L. Van Driest, Tracy L. McGregor · 2013 · Personalized Medicine
41. Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefits
    Clodagh S. O’Gorman, Louise S. Conwell, Michael F. O‘Neill · 2010 · Vascular Health and Risk Management
42. Management of dyslipidemia in children
    Sanjay Kalra, Arun Gandhi, Bharti Kalra, Navneet Kumar Agrawal · 2009 · Diabetology & Metabolic Syndrome
43. Psoriasis and metabolic and cardiovascular comorbidities in children: A systematic review
    Antoine Badaoui, Patrick Tounian, Emmanuel Mahé · 2019 · Archives de Pédiatrie
44. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
    Gisle Langslet, Leiv Ose · 2013 · Expert Review of Cardiovascular Therapy
45. Effectiveness of Omega-3 Polysaturated Fatty Acids (Fish Oil) Supplementation for Treating Hypertriglyceridemia in Children and Adolescents
    Nita Chahal, Cedric Manlhiot, Helen Wong, Brian W. McCrindle · 2014 · Clinical Pediatrics
46. Poor Performance of Body Mass Index as a Marker for Hypercholesterolemia in Children and Adolescents
    Joyce M. Lee, Achamyeleh Gebremariam, Paula Card-Higginson, Jennifer L. Shaw, Joseph W. Thompson, Matthew M. Davis · 2009 · Archives of Pediatrics and Adolescent Medicine
47. Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease
    Catherine J. McNeal, Tala Dajani, Don P. Wilson, Andrea E. Cassidy‐Bushrow, Justin B. Dickerson, Marcia G. Ory · 2010 · Current Atherosclerosis Reports
48. Universal Lipid Screening in 9- to 11-Year-Olds Before and After 2011 Guidelines
    Nicole L. Mihalopoulos, Carole H. Stipelman, Joni Hemond, Laura L. Brown, Paul C. Young · 2017 · Academic Pediatrics
49. Management of type 2 diabetes in youth: an update.
    KEVIN A. PETERSON, Janet H. Silverstein, FRANCINE RATNER KAUFMAN, Elizabeth Warren‐Boulton · 2007 · PubMed
50. Preventing Early Cardiovascular Death in Patients With Familial Hypercholesterolemia
    Thomas B. Repas, J. Ross Tanner · 2014 · Journal of Osteopathic Medicine
51. Effectiveness and Safety of Statin Therapy in Children: A Real-World Clinical Practice Experience
    Rae-Ellen W. Kavey, Cedric Manlhiot, Kyle Runeckles, Tanveer H. Collins, Samuel S. Gidding, Matthew M. Demczko, Sarah B. Clauss, Ashraf S. Harahsheh, Michele Mietus-Syder, Michael Khoury et al. · 2020 · CJC Open
52. Familial hypercholesterolaemia in children and adolescents: A new paediatric model of care
    Andrew C. Martin, John C Coakley, David Forbes, DAVID R. SULLIVAN, Gerald Francis Watts · 2012 · Journal of Paediatrics and Child Health
53. Cardiovascular risk in the young type 1 diabetes population with a low 10‐year, but high lifetime risk of cardiovascular disease
    Gary Eugene McVeigh, W. Gibson, Paul Hamilton · 2012 · Diabetes Obesity and Metabolism
54. High Prevalence of Lipid Abnormalities among Antiretroviral-Naive HIV-Infected Asian Children with Mild-To-Moderate Immunosuppression
    the PREDICT study group, Suparat Kanjanavanit, Thanyawee Puthanakit, Ung Vibol, Pope Kosalaraksa, Rawiwan Hansudewechakul, Chaiwat Ngampiyasakul, Jurai Wongsawat, Wicharn Luesomboon, Jiratchaya Wongsabut et al. · 2011 · Antiviral Therapy
55. Prevalence, Characteristics, and Risk Factors of Elevated Triglyceride Levels in US Children
    Jennifer Briley Christian, Maneesh Juneja, Amy M. Meadowcroft, Spencer Borden, Kimberly Anne Lowe · 2011 · Clinical Pediatrics
56. Intermediate-Term Efficacy and Tolerance of Statins in Children
    N. Mamann, Julie Lemale, Alexandra Karsenty, Béatrice Dubern, J.-P. Girardet, Patrick Tounian · 2019 · The Journal of Pediatrics
57. Atherosclerosis prevention and treatment in children and adolescents
    Fernanda Luísa Ceragioli Oliveira, Rose Vega Patin, Maria Arlete Meil Schimith Escrivão · 2010 · Expert Review of Cardiovascular Therapy
58. An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia
    Kuan Gandelman, Paul Glue, Rachel E. Laskey, Jonathan Jones, Robert R. LaBadie, Leiv Ose · 2011 · Pediatric Cardiology
59. Novel Pathogenic Insights in the Primary Prevention of Cardiovascular Disease
    Claudio Napoli A, Francesco Cacciatore · 2009 · Progress in Cardiovascular Diseases
60. Pitavastatin: evidence for its place in treatment of hypercholesterolemia
    Peter Alagona · 2010 · Core evidence
61. Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials
    Yael Lebenthal, Andrea Horvath, Piotr Dziechciarz, Hania Szajewska, Raanan Shamir · 2010 · Archives of Disease in Childhood
62. Developmental Mechanisms Involved in the Primary Prevention of Atherosclerosis and Cardiovascular Disease
    Claudio Napoli A · 2011 · Current Atherosclerosis Reports
63. Clinical and laboratory assessment of cardiovascular risk in children: Guidelines for screening, evaluation, and treatment
    Peter O. Kwiterovich · 2008 · Journal of clinical lipidology
64. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward
    Raul Dias Santos, Thiago Silva Frauches, Ana Paula Marte Chacra · 2015 · Journal of Atherosclerosis and Thrombosis
65. Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
    Carolina Pereira, Marcio Hiroshi Miname, Marcia Regina Pinho Makdisse, Roberto Kalil Filho, Raul Dias Santos · 2014 · Arquivos Brasileiros de Cardiologia
66. Pediatric guidelines for dyslipidemia
    Stephen R. Daniels · 2015 · Journal of clinical lipidology
67. Abdominal obesity is associated with cardiovascular risk in Japanese children and adolescents
    Satoru Iwashima, Yuichi Nakagawa, Takamichi Ishikawa, Shinichirou Sano Eiichiro Satake, Eiko Nagata, Takehiko Ohzeki · 2011 · Journal of Pediatric Endocrinology and Metabolism
68. Exercise and the obese child
    Sandra G. Hassink, Frances R. Zappalla, Lauren Falini, George A. Datto · 2008 · Progress in Pediatric Cardiology
69. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives
    Claudia Sanna, Xavier Stéphenne, Nicole Revençu, Françoise N. Smets, Agnès Sassolas, Mathilde Di Filippo, Olivier S Descamps, Etienne Marc Sokal · 2016 · Atherosclerosis
70. The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population
    Michael Khoury, Brian W. McCrindle · 2020 · Canadian Journal of Cardiology
71. Cardiovascular Disease in Children and Adolescents with Diabetes: Where Are We, and Where Are We Going?
    Uyen T. Truong, David M. Maahs, Stephen R. Daniels · 2012 · Diabetes Technology & Therapeutics
72. Review: Obesity and cardiometabolic syndrome in children
    Pedro Velasquez‐Mieyer, Claudia P. Neira, Ramfis E Nieto-Martínez, Patricia Ann Cowan · 2007 · Therapeutic Advances in Cardiovascular Disease
73. Statins and Children
    Evan A. Stein · 2007 · Circulation
74. Dyslipidaemia and insulin resistance in vertically HIV-infected children and adolescents
    Lígia Cardoso dos Reis, Patrícia Helen de Carvalho Rondó, Heloísa Helena de Sousa Marques, Samantha Brasil de Andrade · 2011 · Transactions of the Royal Society of Tropical Medicine and Hygiene
75. Familial Hypercholesterolemia
    Victoria Enchia Bouhairie, Anne Carol Goldberg · 2016 · Endocrinology and Metabolism Clinics of North America
76. The prodromal phase of obesity-related chronic kidney disease: early alterations in cardiovascular and renal function in obese children and adolescents
    Anke Doyon, F. Schaefer · 2013 · Nephrology Dialysis Transplantation
77. Metabolic Syndrome in the Pediatric Population: A Short Overview
    Nataša Marčun Varda, Alojz Gregorič · 2009 · Pediatric Reports
78. Renal complications following lung and heart-lung transplantation
    Paul D. Robinson, Rukshana C. Shroff, Helen Spencer · 2012 · Pediatric Nephrology
79. Lipodystrophy in children and adolescents with acquired immunodeficiency syndrome and its relationship with the antiretroviral therapy employed
    Roseli Oselka Saccardo Sarni, Fabíola Isabel Suano de Souza, Tânia Regina Beraldo Battistini, Tassiana Sacchi Pitta, Ana Paula Fernandes, Priscila Chemiotti Tardini, Fernando Luis Affonso Fonseca, Valter Pinho dos Santos, Fábio Ancona Lopez · 2009 · Jornal de Pediatria
80. What is the best treatment for prediabetes?
    Morali D. Sharma, Alan J. Garber · 2009 · Current Diabetes Reports
81. Association between Birth Weight and Cardiovascular Risk Factors in Adolescents
    Maria Amenaide Carvalho Alves de Sousa, Isabel Cristina Britto Guimarães, Carla Hilário da Cunha Daltro, Armênio Costa Guimarães · 2013 · Arquivos Brasileiros de Cardiologia
82. Isolated Low HDL Cholesterol Emerges as the Most Common Lipid Abnormality Among Obese Adolescents
    Zeev Harel, Suzanne Riggs, Rosalind M. Vaz, Patricia Flanagan, Dalia Harel · 2009 · Clinical Pediatrics
83. Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia
    Pascale Benlian, Anne Turquet, Fabrice Carrat, Sabine Amsellem, Lydie Sanchez, Dorothée Briffaut, Jean Philippe Girardet · 2009 · Journal of Pediatric Gastroenterology and Nutrition
84. Hyperlipidaemia in Paediatric Patients
    Anthony S. Wierzbicki, Adie Viljoen · 2010 · Drug Safety
85. Heterozygous familial hypercholesterolaemia in childhood: Cardiovascular risk prevention
    Anouk van der Graaf, John J.P. Kastelein, Albert Wiegman · 2009 · Journal of Inherited Metabolic Disease
86. Atherogenic Lipoprotein Particle Size and Concentrations and the Effect of Pravastatin in Children with Familial Hypercholesterolemia
    Anouk van der Graaf, Jessica Rodenburg, Maud N. Vissers, Barbara A. Hutten, Albert Wiegman, Mieke D. Trip, Erik S.G. Stroes, Frits A. Wijburg, James D. Otvos, John J.P. Kastelein · 2008 · The Journal of Pediatrics
87. Summary of the American Heart Association’s Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents
    Brian W. McCrindle · 2007 · Arteriosclerosis Thrombosis and Vascular Biology
88. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades
    Avishay Elis, Rong Zhou, Evan A. Stein · 2013 · Cardiology in the Young
89. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
    D. Meeike Kusters, B.A. Hutten, Brian W. McCrindle, David M Cassiman, Gordon A. Francis, Claude Gagné, Daniel Gaudet, Katherine Mary Morrison, Gisle Langslet, John J.P. Kastelein et al. · 2013 · Journal of clinical lipidology
90. Management of dyslipidemia in pediatric renal transplant recipients
    Margret Bock, Leslie Wall, Carly Dobrec, Mary Moss Chandran, Jens Goebel · 2020 · Pediatric Nephrology
91. Plasma Non–cholesterol Sterols: A Useful Diagnostic Tool in Pediatric Hypercholesterolemia
    Davide Noto, Angelo Baldassare Cefalu, Giacoma Barraco, Eliana Martino, Francesca Fayer, Mariangela Minà, Anna Montali, Marcello Arca, Maurizio Rocco Averna, Francesco Martino · 2010 · Pediatric Research
92. Hipercolesterolemia. Abordaje terapéutico
    Ana Moráis López, Rosa A. Lama More, J. Dalmau Serra · 2009 · Anales de Pediatría
93. Management of hyperlipidemia in pediatrics
    Stephen R. Daniels · 2012 · Current Opinion in Cardiology
94. Screening and Treatment of Dyslipidemias in Children and Adolescents
    Stephen R. Daniels · 2011 · Hormone Research in Paediatrics
95. Detecting and treating hyperlipidemia in children with type 1 diabetes mellitus: are standard guidelines applicable to this special population?*
    Nicole S. Glaser, David H. Geller, Andrea Maria Haqq, Stephen Eric Gitelman, Mary J. Malloy · 2010 · Pediatric Diabetes
96. Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
    Martin Heier, Knut Haakon Stensæth, Cathrine Brunborg, Ingebjørg Seljeflot, Hanna Dis Margeirsdottir, Kristian Folkvord Hanssen, Knut Dahl‐Jørgensen · 2017 · European Heart Journal - Cardiovascular Imaging
97. Two Siblings with Familial Chylomicronemia Syndrome: Disease Course and Effectiveness of Early Treatment
    Hanan Said Al Azkawi, Ibrahim A. Al-Alwan · 2010 · Case Reports in Medicine
98. Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
    Alpo F. Vuorio, Gerald Francis Watts, Petri T. Kovanen · 2016 · European Heart Journal
99. Risks and Benefits of Statin Use in Young People with Type 1 Diabetes
    Petter Bjornstad, Raj Paul Wadwa · 2014 · Current Diabetes Reports
100. Association of Lipid Abnormalities With Measures and Severity of Adiposity and Insulin Resistance Among Overweight Children and Adolescents
     Sarita Dhuper, Sherry Sakowitz, Josephine Daniels, Sujatha Buddhe, Hillel W. Cohen · 2009 · Journal of Clinical Hypertension